查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1947535

醫療保健資料貨幣化市場：依資料類型、貨幣化模式、應用程式和最終用戶劃分 - 全球預測至 2036 年

Healthcare Data Monetization Market by Data Type, by Monetization Model, by Application, and by End User - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 287 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

全球醫療保健數據貨幣化市場預計將從 2026 年的 5.697 億美元增長到 2036 年的約 287 億美元，預測期內（2026-2036 年）複合年增長率 (CAGR) 為 17.6%。本報告對全球五大主要地區的醫療保健數據貨幣化市場進行了詳細分析，重點關注當前市場趨勢、市場規模、近期發展以及至 2036 年的預測。

基於廣泛的一手和二手研究以及對市場現狀的深入分析，本報告分析了關鍵行業驅動因素、限制因素、機會和挑戰的影響。推動醫療保健數據貨幣化市場成長的關鍵因素包括全球對數據驅動型醫療保健服務的日益重視以及人工智慧的快速應用。 此外，隱私增強技術的整合、對高品質醫療數據集日益增長的需求以及聯邦數據網路的擴展，預計將為醫療保健數據貨幣化市場中的公司創造巨大的成長機會。

市場區隔

目錄

第一章：引言

第二章：摘要整理

第三章：市場概覽

  • 市場動態
    • 驅動因素
    • 限制因素
    • 機遇
    • 挑戰
  • 人工智慧 (AI) 和雲端技術對醫療保健數據貨幣化的影響
  • 監管環境與資料隱私框架
  • 波特五力模型分析

第四章 全球醫療保健資料貨幣化市場（依資料類型劃分）

  • 臨床數據
    • 電子健康記錄 (EHR) 數據
    • 醫學影像數據
    • 實驗室和診斷數據
  • 計費和財務數據
    • 保險索賠數據
    • 計費和報銷數據
  • 藥物及研發數據
    • 臨床試驗數據
    • 藥物利用與治療結果數據
  • 患者產生數據
    • 穿戴式裝置和遠端監測數據
    • 消費者健康應用數據
  • 營運與管理數據
    • 員工與工作安排數據
    • 供應鏈與採購數據

第五章：全球醫療保健資料貨幣化市場（以貨幣化模式劃分）

  • 內部貨幣化
    • 營運效率和成本降低
    • 改善臨床績效
  • 外在貨幣化
    • 資料許可和資料即服務 (DaaS)
    • 研究與分析合作
    • 真實世界數據市場

第六章：全球醫療保健數據貨幣化市場（依應用劃分）

  • 藥物發現與開發
  • 臨床試驗管理
  • 人群健康管理
  • 收入周期管理
  • 精準醫療
  • 醫療保健營運優化

第七章：全球醫療保健數據依最終用戶劃分的貨幣化市場

  • 製藥和生技公司
    • 大藥廠
    • 專業製藥和生技公司
  • 醫療保健提供者
    • 醫院系統與綜合護理網絡
    • 門診和專科護理提供者
  • 支付方
    • 私人健康保險公司
    • 政府和公共支付方
  • 醫療器材製造商
    • 診斷設備製造商
    • 數位健康與穿戴式裝置公司
  • 醫療資訊科技公司
    • 電子健康記錄 (EHR) 和健康資訊系統供應商
    • 健康分析平台提供者
  • 政府和研究機構機構
    • 學術醫療中心
    • 公共衛生與國家研究機構

第八章 全球醫療保健資料貨幣化市場（依地區劃分）

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 東南亞
    • 澳大利亞
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區

第九章 競爭格局

  • 關鍵成長策略
  • 競爭標竿分析
  • 競爭概覽
    • 行業領導者
    • 市場差異化因素
    • 先鋒企業
    • 新興企業
  • 主要企業市場排名/定位分析（2025 年）

第10章 企業簡介(產業概要，財務概要，產品系列，策略性展開，SWOT分析)

  • IQVIA Holdings Inc.
  • Optum Inc.(UnitedHealth Group)
  • Oracle Health(formerly Cerner Corporation)
  • Merative(formerly IBM Watson Health)
  • Komodo Health Inc.
  • Inovalon Holdings Inc.
  • Datavant Inc.
  • Definitive Healthcare Corp.
  • Veeva Systems Inc.
  • Flatiron Health Inc.(Roche Group)
  • Health Catalyst Inc.
  • Innovaccer Inc.

第11章 附錄

簡介目錄
Product Code: MRHC - 1041791

Healthcare Data Monetization Market by Data Type (Clinical Data, Claims & Financial Data, Pharmaceutical & R&D Data, Patient-Generated Data, Operational & Administrative Data), Monetization Model (Internal Monetization, External Monetization), Application, and End User - Global Forecast to 2036

According to the research report titled, 'Healthcare Data Monetization Market by Data Type (Clinical Data, Claims & Financial Data, Pharmaceutical & R&D Data, Patient-Generated Data, Operational & Administrative Data), Monetization Model (Internal Monetization, External Monetization), Application, and End User - Global Forecast to 2036,' the global healthcare data monetization market is expected to reach approximately USD 28.7 billion by 2036 from USD 569.7 million in 2026, at a CAGR of 17.6% during the forecast period (2026-2036). The report provides an in-depth analysis of the global healthcare data monetization market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036.

Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the healthcare data monetization market include the intensifying global focus on data-driven care delivery and the rapid expansion of artificial intelligence adoption. Additionally, the integration of privacy-enhancing technologies, increasing demand for high-quality health datasets, and expansion of federated data networks are expected to create significant growth opportunities for players operating in the healthcare data monetization market.

Market Segmentation

The healthcare data monetization market is segmented by data type (clinical data, claims & financial data, pharmaceutical & R&D data, patient-generated data, operational & administrative data), monetization model (internal monetization, external monetization), application, and end user. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Data Type

By data type, the clinical data segment holds the largest market share in 2026, primarily attributed to the breadth and depth of structured and unstructured clinical records generated across hospitals and ambulatory care settings globally. Clinical data represents the most commercially valuable health data asset. However, the pharmaceutical & R&D data segment is expected to grow at the fastest CAGR during the forecast period, driven by the increasing demand for real-world clinical datasets to accelerate candidate identification and support regulatory submissions. Claims & financial data, patient-generated data, and operational & administrative data represent specialized segments with rapid growth potential.

Based on Monetization Model

By monetization model, the external monetization segment holds the largest market share in 2026, owing to the high commercial demand for licensed health datasets and data-as-a-service offerings from pharmaceutical, biotechnology, and research organizations. External monetization represents the primary revenue driver for healthcare data companies. The internal monetization segment is expected to witness significant growth during the forecast period, driven by healthcare organizations seeking to unlock strategic value from their proprietary data assets and improve operational efficiency.

Based on Application

By application, the drug discovery and development segment holds the largest share of the overall market in 2026, as pharmaceutical companies increasingly rely on real-world clinical datasets to accelerate candidate identification and support regulatory submissions. Drug discovery represents the most established application for health data monetization. Real-world evidence generation, precision medicine, and population health management represent emerging applications with significant growth potential.

Based on End User

By end user, the pharmaceutical and biotechnology companies segment holds the largest share of the overall market in 2026, reflecting their sustained demand for high-quality health datasets to support drug development and clinical research. Pharmaceutical and biotechnology companies represent the primary market driver. Healthcare providers, payers, research institutions, and other end-user segments represent emerging markets with rapid growth potential.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America dominates the global healthcare data monetization market with the largest market share, primarily attributed to a mature health information technology infrastructure and high electronic health record adoption rates in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by rapid digitization of healthcare systems and government-backed national health data initiatives in China, India, Japan, and Southeast Asia. Europe, Latin America, and the Middle East & Africa represent emerging markets with growing emphasis on data-driven healthcare and real-world evidence programs.

Key Players

The key players operating in the global healthcare data monetization market are IQVIA Holdings Inc., Optum Inc., Inovalon Holdings Inc., Komodo Health Inc., Datavant Inc., Flatiron Health (Roche), Tempus AI, Veradigm LLC, and various other regional and emerging health data analytics and data monetization service providers, among others.

Key Questions Answered in the Report-

  • What is the current revenue generated by the healthcare data monetization market globally?
  • At what rate is the global healthcare data monetization market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global healthcare data monetization market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of data type, monetization model, application, and end user are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global healthcare data monetization market?
  • Who are the major players in the global healthcare data monetization market? What are their specific product offerings in this market?
  • What are the recent strategic developments in the global healthcare data monetization market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Healthcare Data Monetization Market Assessment -- by Data Type

  • Clinical Data
  • Claims & Financial Data
  • Pharmaceutical & R&D Data
  • Patient-Generated Data
  • Operational & Administrative Data

Healthcare Data Monetization Market Assessment -- by Monetization Model

  • Internal Monetization
  • External Monetization

Healthcare Data Monetization Market Assessment -- by Application

  • Drug Discovery and Development
  • Real-World Evidence Generation
  • Precision Medicine
  • Population Health Management
  • Others

Healthcare Data Monetization Market Assessment -- by End User

  • Pharmaceutical and Biotechnology Companies
  • Healthcare Providers
  • Payers
  • Research Institutions
  • Others

Healthcare Data Monetization Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Scope
  • 1.3. Research Methodology
  • 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
    • 3.2.4. Challenges
  • 3.3. Impact of AI and Cloud Technologies on Healthcare Data Monetization
  • 3.4. Regulatory Landscape & Data Privacy Frameworks
  • 3.5. Porter's Five Forces Analysis

4. Global Healthcare Data Monetization Market, by Data Type

  • 4.1. Introduction
  • 4.2. Clinical Data
    • 4.2.1. Electronic Health Records (EHR) Data
    • 4.2.2. Medical Imaging Data
    • 4.2.3. Laboratory & Diagnostic Data
  • 4.3. Claims & Financial Data
    • 4.3.1. Insurance Claims Data
    • 4.3.2. Billing & Reimbursement Data
  • 4.4. Pharmaceutical & R&D Data
    • 4.4.1. Clinical Trial Data
    • 4.4.2. Drug Utilization & Outcomes Data
  • 4.5. Patient-Generated Data
    • 4.5.1. Wearable & Remote Monitoring Data
    • 4.5.2. Consumer Health Application Data
  • 4.6. Operational & Administrative Data
    • 4.6.1. Workforce & Scheduling Data
    • 4.6.2. Supply Chain & Procurement Data

5. Global Healthcare Data Monetization Market, by Monetization Model

  • 5.1. Introduction
  • 5.2. Internal Monetization
    • 5.2.1. Operational Efficiency & Cost Reduction
    • 5.2.2. Clinical Performance Improvement
  • 5.3. External Monetization
    • 5.3.1. Data Licensing & Data-as-a-Service (DaaS)
    • 5.3.2. Research & Analytics Partnerships
    • 5.3.3. Real-World Data Marketplaces

6. Global Healthcare Data Monetization Market, by Application

  • 6.1. Introduction
  • 6.2. Drug Discovery & Development
  • 6.3. Clinical Trials Management
  • 6.4. Population Health Management
  • 6.5. Revenue Cycle Management
  • 6.6. Precision Medicine
  • 6.7. Healthcare Operations Optimization

7. Global Healthcare Data Monetization Market, by End User

  • 7.1. Introduction
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Large Pharmaceutical Companies
    • 7.2.2. Specialty Pharma & Biotech Firms
  • 7.3. Healthcare Providers
    • 7.3.1. Hospital Systems & Integrated Delivery Networks
    • 7.3.2. Ambulatory & Specialty Care Providers
  • 7.4. Payers
    • 7.4.1. Commercial Health Insurers
    • 7.4.2. Government & Public Payers
  • 7.5. Medical Device Manufacturers
    • 7.5.1. Diagnostic Device Companies
    • 7.5.2. Digital Health & Wearable Device Companies
  • 7.6. Healthcare IT Companies
    • 7.6.1. EHR & Health Information System Vendors
    • 7.6.2. Health Analytics Platform Providers
  • 7.7. Government & Research Institutions
    • 7.7.1. Academic Medical Centers
    • 7.7.2. Public Health Agencies & National Research Bodies

8. Global Healthcare Data Monetization Market, by Region

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Netherlands
    • 8.3.7. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. India
    • 8.4.3. Japan
    • 8.4.4. South Korea
    • 8.4.5. Southeast Asia
    • 8.4.6. Australia
    • 8.4.7. Rest of Asia-Pacific
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Rest of Latin America
  • 8.6. Middle East & Africa
    • 8.6.1. Saudi Arabia
    • 8.6.2. UAE
    • 8.6.3. South Africa
    • 8.6.4. Rest of Middle East & Africa

9. Competitive Landscape

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Ranking / Positioning Analysis of Key Players, 2025

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)

  • 10.1. IQVIA Holdings Inc.
  • 10.2. Optum Inc. (UnitedHealth Group)
  • 10.3. Oracle Health (formerly Cerner Corporation)
  • 10.4. Merative (formerly IBM Watson Health)
  • 10.5. Komodo Health Inc.
  • 10.6. Inovalon Holdings Inc.
  • 10.7. Datavant Inc.
  • 10.8. Definitive Healthcare Corp.
  • 10.9. Veeva Systems Inc.
  • 10.10. Flatiron Health Inc. (Roche Group)
  • 10.11. Health Catalyst Inc.
  • 10.12. Innovaccer Inc.

11. Appendix

  • 11.1. Questionnaire
  • 11.2. Related Reports